Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:600165'
s PB Ratio Range Over the Past 10 Years
Min: 2.54 Med: 6.61 Max: 479.09
Current: 3.42
During the past 13 years, Ningxia Zhongke Biotechnology Co's highest PB Ratio was 479.09. The lowest was 2.54. And the median was 6.61.
SHSE:600165's PB Ratio is ranked worse than 78.62% of 1576
companies
in the Chemicals industry
Industry Median: 1.66
vs SHSE:600165: 3.42
During the past 12 months, Ningxia Zhongke Biotechnology Co's average Book Value Per Share Growth Rate was 6336.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -2.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -29.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -16.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Ningxia Zhongke Biotechnology Co was 54.70% per year. The lowest was -54.60% per year. And the median was -1.45% per year.
Back to Basics: PB Ratio
Ningxia Zhongke Biotechnology Co (SHSE:600165) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Ningxia Zhongke Biotechnology Co PB Ratio Related Terms
Ningxia Zhongke Biotechnology Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Ningxia Zhongke Biotechnology Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ningxia Zhongke Biotechnology Co PB Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Ningxia Zhongke Biotechnology Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Ningxia Zhongke Biotechnology Co's PB Ratio falls into.
Ningxia Zhongke Biotechnology Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Ningxia Zhongke Biotechnology Co (SHSE:600165) has a PB Ratio of 3.43 as of Jul. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Ningxia Zhongke Biotechnology Co and its competitors. This is 48% below median its historical median of 6.61. Over the past decade, Ningxia Zhongke Biotechnology Co's PB Ratio has ranged from 2.54 to 479.09. According to the industry distribution chart, Ningxia Zhongke Biotechnology Co ranks #1239 out of 1576 companies in the Chemicals industry, placing it in the top 78.6%.
Is Ningxia Zhongke Biotechnology Co's PB Ratio too high?
Ningxia Zhongke Biotechnology Co's current PB Ratio of 3.43 is 48% below median its 10-year median of 6.61. Over the past 10 years, this metric has ranged from a low of 2.54 to a high of 479.09. The Chemicals industry median PB Ratio is 1.66. Ningxia Zhongke Biotechnology Co's value of 3.43 is 106.6% above this industry median. Based on the distribution chart, Ningxia Zhongke Biotechnology Co ranks #1239 out of 1576 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Ningxia Zhongke Biotechnology Co has a GF Score™ of 53/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ningxia Zhongke Biotechnology Co's PB Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, Ningxia Zhongke Biotechnology Co ranks #1239 out of 1576 companies for PB Ratio. This places Ningxia Zhongke Biotechnology Co in the lower half of its industry. The industry median PB Ratio is 1.66. Ningxia Zhongke Biotechnology Co's value of 3.43 is 106.6% above this benchmark. Historically, Ningxia Zhongke Biotechnology Co's own PB Ratio has ranged from 2.54 to 479.09 over the past decade. While the company's 10-year median is 6.61 vs. the industry median of 1.66, Ningxia Zhongke Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Chemicals company?
The median PB Ratio among Chemicals companies is 1.66, based on 1,576 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ningxia Zhongke Biotechnology Co's current PB Ratio of 3.43 is 106.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Ningxia Zhongke Biotechnology Co and its competitors. For the Chemicals industry, the median PB Ratio is 1.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ningxia Zhongke Biotechnology Co's current PB Ratio is 3.43, which is 48% below median its own 10-year median of 6.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningxia Zhongke Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co (SHSE:600165) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥2.77, compared to a current price of ¥2.43 — trading 12.3% below its estimated fair value. The current PB Ratio is 3.43, which is 48% below median its 10-year median of 6.61 and 106.6% above the Chemicals industry median of 1.66. Ningxia Zhongke Biotechnology Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Ningxia Zhongke Biotechnology Co (SHSE:600165), the current PB Ratio is 3.43 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ningxia Zhongke Biotechnology Co (SHSE:600165) Overvalued in 2026?
Based on GuruFocus' analysis, Ningxia Zhongke Biotechnology Co stock appears to be undervalued.
The current stock price of ¥2.43 is trading 12.3% below its estimated GF Value™ of ¥2.77.
GuruFocus considers Ningxia Zhongke Biotechnology Co to be Modestly Undervalued.
Key valuation signals for SHSE:600165:
PB Ratio: 3.43 (48% below median its 10-year median of 6.61)
GF Value™: ¥2.77 vs. price of ¥2.43 (12.3% below fair value)
Industry Position: 106.6% above the Chemicals median (#1239 of 1576)
No single metric tells the full story. See the SHSE:600165 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ningxia Zhongke Biotechnology Co Business Description
Ningxia Zhongke Biotechnology Co Ltd is engaged in the production and sales of activated carbon products, preparation and storage of stem cells, trade and other businesses, as well as lauric acid.
53GF Score
Get the complete analysis for SHSE:600165
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600165 has been successfully added to your 
